Armata Pharmaceuticals, Inc. Common Stock (ARMP)
SG&A Expenses
$15.24M
TTM · Period ending: · USD
ARMP SG&A Expenses
Latest reported$15.24Mperiod ending
Latest reported$15.24Mperiod ending
ARMP TTM SG&A Expenses ($0.00 → $15.24M)
TTM SG&A Expenses
High-resolution chart · PNG
ARMP sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 15,236,000 | |
| 12,619,000 | |
| 12,409,000 | |
| 12,306,000 | |
| 12,439,000 | |
| 13,259,000 | |
| 13,184,000 | |
| 13,040,000 | |
| 13,158,000 | |
| 11,869,000 | |
| 11,229,000 | |
| 9,860,000 | |
| 8,059,000 | |
| 7,992,000 | |
| 7,437,000 | |
| 7,850,000 | |
| 8,057,000 | |
| 8,113,000 | |
| 8,281,000 | |
| 8,035,000 | |
| 8,112,000 | |
| 7,946,000 | |
| 7,966,000 | |
| 7,732,000 | |
| 9,645,000 | |
| 9,754,000 | |
| 8,963,000 | |
| 8,695,000 | |
| 6,213,000 | |
| 5,491,000 | |
| 5,702,000 | |
| 5,522,000 | |
| 5,859,000 | |
| 7,283,000 | |
| 7,590,000 | |
| 7,832,000 | |
| 8,000,000 | |
| 7,667,000 | |
| 8,413,000 | |
| 8,729,000 | |
| 8,791,000 | |
| 7,957,000 | |
| 6,710,000 | |
| 4,834,000 | |
| 4,692,000 | |
| 5,226,000 | |
| 5,456,000 | |
| 9,516,000 | |
| 9,030,000 | |
| 9,722,000 | |
| 8,809,000 | |
| 6,124,000 | |
| 5,945,000 | |
| 4,463,000 | |
| 4,706,000 | |
| 4,578,000 | |
| 5,294,000 | |
| 5,822,000 | |
| 7,073,000 | |
| 7,543,000 | |
| 7,366,000 | |
| 7,029,000 | |
| 6,467,000 | |
| 6,460,000 | |
| 6,453,000 | |
| 6,382,000 | |
| 6,014,000 | |
| 5,817,000 | |
| 5,909,000 | |
| 6,313,000 | |
| 6,393,000 | |
| 6,379,000 | |
| 6,785,000 | |
| 6,650,000 | |
| 6,875,000 | |
| 6,532,000 | |
| 5,904,000 | |
| 5,490,000 | |
| 7,520,000 | |
| 7,609,000 | |
| 7,750,000 | |
| 8,809,000 | |
| 6,462,000 | |
| 6,708,000 | |
| 6,571,000 | |
| 6,203,000 | |
| 7,327,000 | |
| 6,978,000 | |
| 6,628,000 | |
| 5,708,000 | |
| 1,318,000 | |
| 1,199,000 | |
| 807,000 | |
| 500,000 | |
| 3,400,000 | |
| 3,100,000 | |
| 3,100,000 | |
| 3,100,000 | |
| 2,900,000 | |
| 2,900,000 |